DEER PARK, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused...
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -50.00% and +8.48%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what...
Image source: The Motley Fool.DateMay 7, 2026Call participantsPresident and Chief Executive Officer — Ian MortimerChief Medical Officer — Christopher John KenneyChief...
